HomeOpen Access News

Open Access News

New supercapacitor technology captures CO2 and generates energy

Researchers at Politecnico di Torino have developed new energy storage technology that could help tackle two major global challenges: reducing industrial carbon emissions and boosting renewable energy efficiency.

How blockchain can protect businesses against CV fraud

As the job market becomes more saturated during the pandemic, employers and recruiters will need to pay more attention to fraudulent applications. Here, René Seifert, co-head of TrueProfile.io, explores how blockchain technology can be deployed to combat CV fraud.

Scientists investigate possible link between opioids and pancreatic cancer

The team at Rush University Medical Center have conducted the first US investigation into opioid use and pancreatic cancer - how could this change prescriptions?

UKRI invests £213 million to upgrade the UK’s research infrastructure

UK Research and Innovation (UKRI) is investing £213 million to expand and upgrade the UK's existing research infrastructure to help tackle major challenges such as COVID-19 research and recovery, and net-zero goals.

Coventry and Oxford set to be first all-electric bus cities in the UK

Proposals to see Coventry and Oxford as the UK's first all-electric bus cities are currently underway, Transport Secretary Grant Shapps has announced.

COVID positive smokers are twice as likely to be hospitalised

According to research by King's College London with 2.4 million participants, smokers with COVID-19 are twice as likely to be hospitalised.

How to practise conscious consumerism in a post-pandemic world

Michael Stausholm, founder of Sprout World, discusses what companies and consumers should be doing to contribute to a more responsible and sustainable society.

There is not enough research on traumatic brain injury in women

According to the National Institute of Neurological Disorders and Stroke, there are gaps in knowledge on the effects of traumatic brain injury (TBI) in women.

Moderna vaccine approved for use by European Medicines Agency

The EMA joins the US in approving the 94.1% effective Moderna vaccine for use, while the UK still waits on further regulatory discussions.

Earlier lung cancer diagnosis research receives £3.5 million from UKRI

UK Research and Innovation (UKRI) has awarded £3.5 million-worth of funding to help ground-breaking medical research find new ways to diagnose lung cancer earlier.

Are revolutionary inventions being suppressed because they provide energy independence?

Hydrogen is a known game-changer for the future of renewable, clean energy - but is the concept of energy independence part of the reason why some revolutionary inventions are being suppressed?

A new era in cardiac diagnosis

Justin Hall, GM and VP EMEA, iRhythm Technologies, explores how modern technology is helping to diagnose Atrial Fibrillation (AF).

Technology use and sleep disorders in the U.S.

Technology has always been condemned in multiple empirical studies highlighting blue light effects on overall sleep quality. However, with the rise of sleep tech in recent years, could this digital insurgence be the catalyst for a public’s change of heart?

Ordinary drug could prevent heart damage from breast cancer chemotherapy

Damaged heart muscle is a tragic possibility for patients of breast cancer chemotherapy - but thanks to Dr Husam Abdel-Qadir, there may now be a way to stop it.

Who should tackle the biggest cause of premature death when PHE is gone?

Katharine Jenner, Campaign Director and Mhairi Brown, Policy and Public Affairs Manager of Action on Sugar and Action on Salt debate who should be responsible for tackling the biggest cause of premature death and disability in the UK when Public Health England is dissolved.

Government allocates £4.6 billion in new lockdown grants to support businesses

Chancellor Rishi Sunak has announced that businesses in the retail, hospitality and leisure sectors are to receive a one-off grant worth up to £9,000 amid third UK lockdown.

Infection prevention and control (IPC) for COVID-19 focus

Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of  infection prevention and control in the healthcare sector in light of COVID-19.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders